Literature DB >> 21289350

Changes In US spending on Mental Health And Substance Abuse Treatment, 1986-2005, and implications for policy.

Tami L Mark1, Katharine R Levit, Rita Vandivort-Warren, Jeffrey A Buck, Rosanna M Coffey.   

Abstract

The United States invests a sizable amount of money on treatments for mental health and substance abuse: $135 billion in 2005, or 1.07 percent of the gross domestic product. We provide treatment spending estimates from the period 1986-2005 to build understanding of past trends and consider future possibilities. We find that the growth rate in spending on mental health medications-a major driver of mental health expenditures in prior years-declined dramatically. As a result, mental health and substance abuse spending grew at a slightly slower rate than gross domestic product in 2004 and 2005, and it continued to shrink as a share of all health spending. Of note, we also find that Medicaid's share of total spending on mental health grew from 17 percent in 1986 to 27 percent in 2002 to 28 percent in 2005. The recent recession, the full implementation of federal parity law, and such health reform-related actions as the planned expansion of Medicaid all have the potential to improve access to mental health and substance abuse treatment and to alter spending patterns further. Our spending estimates provide an important context for evaluating the effect of those policies.

Mesh:

Year:  2011        PMID: 21289350     DOI: 10.1377/hlthaff.2010.0765

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  41 in total

1.  Ten-year trends in quality of care and spending for depression: 1996 through 2005.

Authors:  Catherine A Fullerton; Alisa B Busch; Sharon-Lise T Normand; Thomas G McGuire; Arnold M Epstein
Journal:  Arch Gen Psychiatry       Date:  2011-12

2.  Advancing recovery: implementing evidence-based treatment for substance use disorders at the systems level.

Authors:  Laura A Schmidt; Traci Rieckmann; Amanda Abraham; Todd Molfenter; Victor Capoccia; Paul Roman; David H Gustafson; Dennis McCarty
Journal:  J Stud Alcohol Drugs       Date:  2012-05       Impact factor: 2.582

3.  The role of community health centers in providing behavioral health care.

Authors:  Peter Shin; Jessica Sharac Msc; D Richard Mauery
Journal:  J Behav Health Serv Res       Date:  2013-10       Impact factor: 1.505

4.  Do medical marijuana laws reduce addictions and deaths related to pain killers?

Authors:  David Powell; Rosalie Liccardo Pacula; Mireille Jacobson
Journal:  J Health Econ       Date:  2018-02-03       Impact factor: 3.883

5.  State variations in Medicaid enrollment and utilization of substance use services: Results from a National Longitudinal Study.

Authors:  Ramin Mojtabai; Kenneth A Feder; Marc Kealhofer; Noa Krawczyk; Carla Storr; Kayla N Tormohlen; Andrea S Young; Mark Olfson; Rosa M Crum
Journal:  J Subst Abuse Treat       Date:  2018-04-04

6.  The relationship of state Medicaid coverage to Medicaid acceptance among substance abuse providers in the United States.

Authors:  Christina M Andrews
Journal:  J Behav Health Serv Res       Date:  2014-10       Impact factor: 1.505

7.  The impact of Medicaid peer support utilization on cost.

Authors:  Glenn Landers; Mei Zhou
Journal:  Medicare Medicaid Res Rev       Date:  2014-02-18

8.  Predictors of Unmet Family Support Service Needs in Families of Children with Special Health Care Needs.

Authors:  Genevieve Graaf; Izabela Annis; Regina Martinez; Kathleen C Thomas
Journal:  Matern Child Health J       Date:  2021-05-03

9.  Disparities in access to physicians and medications for the treatment of substance use disorders between publicly and privately funded treatment programs in the United States.

Authors:  Amanda J Abraham; Hannah K Knudsen; Traci Rieckmann; Paul M Roman
Journal:  J Stud Alcohol Drugs       Date:  2013-03       Impact factor: 2.582

10.  Which elements of improvement collaboratives are most effective? A cluster-randomized trial.

Authors:  David H Gustafson; Andrew R Quanbeck; James M Robinson; James H Ford; Alice Pulvermacher; Michael T French; K John McConnell; Paul B Batalden; Kim A Hoffman; Dennis McCarty
Journal:  Addiction       Date:  2013-03-01       Impact factor: 6.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.